Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001933400 | SCV002197336 | uncertain significance | not provided | 2021-08-17 | criteria provided, single submitter | clinical testing | This sequence change replaces serine with glycine at codon 736 of the C5 protein (p.Ser736Gly). The serine residue is weakly conserved and there is a small physicochemical difference between serine and glycine. This variant is present in population databases (rs778780304, ExAC 0.001%). This variant has not been reported in the literature in individuals affected with C5-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002503595 | SCV002790230 | uncertain significance | Complement component 5 deficiency; Eculizumab, poor response to | 2021-12-05 | criteria provided, single submitter | clinical testing |